{"schema_version":"secwatch.filing_event.v1","accession":"0001000228-22-000030","form_type":"8-K","ticker":"HSIC","cik":"0001000228","company_name":"HENRY SCHEIN INC","filed_at":"2022-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.186576+00:00","generated_at":"2026-06-26T01:09:38.380451+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Henry Schein Q1 record sales $3.2B (+8.7% YoY), EPS $1.30 beats prior year; reaffirms FY2022 guidance","bullets":["Net sales $3.2B, +8.7% YoY; GAAP diluted EPS $1.30 vs $1.16 YoY.","Global Dental sales $1.8B (+2.2% YoY); Global Medical $1.2B (+18.3%).","Global Technology & Value-Added Services sales $179M (+23.4%), driven by Henry Schein One.","FY2022 GAAP EPS guidance reaffirmed $4.75-$4.91 (7-10% growth); sales growth guidance narrowed to 5-8%.","$200M remaining in share repurchase authority; no shares bought in Q1."],"urls":{"canonical":"https://secwatch.observer/filing/0001000228-22-000030","json":"https://secwatch.observer/filing/0001000228-22-000030.json","markdown":"https://secwatch.observer/filing/0001000228-22-000030.md","text":"https://secwatch.observer/filing/0001000228-22-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000228/000100022822000030/0001000228-22-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000228/000100022822000030/hsic-20220503.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T01:09:38.380451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}